论文信息 - Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT - 字舞流文

Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT

S. Pilotti | L. Rimassa | F. Perrone | R. Passalacqua | A. Lampis | F. Pietrantonio | C. Carbone | P. Biondani | E. Bajetta | M. Di Bartolomeo | C. Bertan | K. Dotti | E. Beretta | O. B. O. T. M. Group | A. Lampis